[Novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin].
Nishikawa
Kiyotaka
K
knishika@mail.doshisha.ac.jp
D020816:Amino Acid Motifs; D000818:Animals; D001692:Biological Transport; D015195:Drug Design; D004721:Endoplasmic Reticulum / Q000378:metabolism; D004927:Escherichia coli Infections / Q000188:drug therapy; D019453:Escherichia coli O157; D006056:Golgi Apparatus / Q000378:metabolism; D006801:Humans; D009844:Oligosaccharides / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D019151:Peptide Library; D022621:Shiga Toxin / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D014281:Trihexosylceramides / Q000378:metabolism
D009844:Oligosaccharides; D019151:Peptide Library; C404684:STARFISH carbohydrate; D014281:Trihexosylceramides; C018549:globotriaosylceramide; D022621:Shiga Toxin